ʻO ka peptide kikoʻī no ka hana hou ʻana: 6 Māhele

Pane wikiwiki

A sequence string is not a material definition. Learn the six fields a peptide specification needs for reproducible results.

No ke aha ʻaʻole ʻo ka Sequence String kahi kikoʻī peptide

he hoʻohālikelike ʻaoʻao ʻaoʻao o kahi kaula kaʻina hana ʻole ma ka hema a me kahi moʻolelo kikoʻī piha ma ka ʻākau, me na mahina eono i nalowale i kapaia o

Hoʻomaka nā palena notation sequence me ka mea i hoʻopaʻa ʻia e ke kaula: hoʻohui, ka hoʻopili ʻana i nā koena. ʻAʻohe mea e pili ana i ka mea āu e pipette ai.

ʻO kahi kikoʻī peptide kahi ʻikepili waiwai, aole inoa. Eono kahua e hoʻoholo i ka hana like ʻana o nā hue ʻelua: kemika hoʻopau, ʻano hoʻohālikelike a me ka paʻakai, maʻiʻo peptide net, maʻemaʻe me kāna ʻano analytical, mālama moʻolelo, a me ka hōʻike ʻana me ka hiki ʻana o ka puʻupuʻu. ʻAʻohe o lākou i ʻike ʻia ma kahi kaʻina.

ʻO ka maʻemaʻe ka laʻana maopopo loa. ʻO ka hoʻomaʻemaʻe HPLC he pili-pili, aole waiwai: ʻO ka pākēneka i hōʻike ʻia ʻo ia ka ʻāpana kiʻekiʻe nui i hoʻohālikelike ʻia i ka ʻāpana piko i hoʻohui ʻia ma lalo o kahi ʻano kikoʻī, a ʻaʻole ia e hoʻokumu i ke kaʻina, nuipa pololei, ʻano paʻakai, ʻano wai, ʻaʻole hoʻi ka nele o nā ʻano co-eluting. Hana like nā mea kū'ē. Haʻalele lākou i ke kaʻina covalent me ka hoʻololi ʻole i ke kūpaʻa, conformation, ka pilina o ka membrane a me ka hana olaola, e like me ka loiloi ʻia ma Nā biomolele e pili ana i nā hopena counterion i ka nānā ʻana a me ka hoʻokumu ʻana o ka peptide (2025).

Ki Takeaway: ʻO kahi kaʻina e wehewehe i ka pilina wale nō; pili ka reproducibility i ka wehewehe mea piha.

No laila ke kauoha hou ʻoe i "ka peptide like,” ʻaʻole ʻae ʻia ʻoe i ka mea like. ʻO ka hana ʻana i kahi kikoʻī peptide no ka reproducibility ʻo ia ka kākau ʻana i nā mahina ʻeono a pau ma mua o ka hiki ʻana mai o ka hailona aʻe.

He aha kāu e pono ai ma mua o kou hoʻomaka ʻana

E hōʻiliʻili i kēia mau mea waiwai ma mua o kou hoʻololi ʻana i kekahi mea ma kāu ʻano hana. Inā e holo ana kahi haʻawina, huki i nā moʻolelo hailona o kēia manawa a me nā moʻolelo mua i hiki iā ʻoe ke hoʻohālikelike iā lākou i kēlā me kēia ʻaoʻao.

  • ʻO ka palapala hōʻoia o ka hailona o kēia manawa, me ka helu hailona i ikeia. ʻO kēia ka palapala e hilinaʻi nei kāu palapala peptide o ka nānā ʻana i ka batch traceability.

  • ʻO ka palapala hōʻoia o ka hailona mua, inā e hoʻomaka ana kāu haʻawina.

  • ʻO ka wehewehe ʻana o ke ʻano HPLC: kolamu, kaʻina lawe lima, gradient, a me ka lōʻihi nalu ʻike.

  • ʻO ka ʻike kikoʻī nui no ka nui āu e hoʻohana nei.

  • ʻO kāu hoʻoponopono hou a me ka waihona waihona.

  • ʻO nā pae hoʻohālikelike ponoʻī o kāu assay, kākau ʻia ma mua o kou hoʻomaka ʻana.

Manaʻo ʻoe ua ʻoluʻolu ʻoe i ka heluhelu ʻana i kahi chromatogram a me kahi palapala hōʻoia. Hoʻolālā ma kahi o hoʻokahi hola e ʻākoakoa a heluhelu i nā mea āpau.

Hoʻokahi hoʻopaʻapaʻa pono: paʻakikī ke loaʻa kekahi o kēia mau māla, a ʻaʻole kēlā me kēia mea hoʻolako i palapala iā lākou. E noi i kāu mea e pono ai, a e nānā i ka mea hiki ʻole ke loaʻa.

ʻanuʻu 1: Kākau i lalo i ke Kemika Terminal, ʻAʻole wale i ka Sequence

he kiʻi hana peptide me ka N-terminus, C-terminus a me hoʻokahi hoʻololi hoʻololi i hōʻike ʻia a hōʻailona ʻia

Ma ka hopena o kēia ʻanuʻu e loaʻa iā ʻoe kahi N-terminus, C-terminus a me ka moʻolelo hoʻololi hoʻololi ma kahi o ka mea i kuhikuhi ʻia, ʻO ia ke kahua mua e lawe ʻia kahi kikoʻī peptide no ka reproducibility.

Hiki ke ʻano like ke kaʻina o loko i ka wā e hoʻololi ai ka termini i nā mea āpau a ka assay e ʻike ai. ʻOkoʻa ka amine N-terminus a me ka acetylated i ka mālama ʻana a me ke ʻano o ka peptide i ka ʻili o kahi pā.; ʻokoʻa ka ʻakika C-terminus a me kahi amide i ka uku ʻupena a me ke kūpaʻa kūʻē i nā exopeptidases. Hoʻololi hou nā lepili terminal a me nā pūnaewele conjugation i nā waiwai like. ʻAʻohe o ia mea i ʻike ʻia ma ke kaula kaʻina, ʻo ia ke kumu ka EMA alakaʻi no ka hoʻomohala ʻana a me ka hana ʻana i nā peptides synthetic mālama i ka kemika terminal ma ke ʻano he kahua kūkulu i kona pono ponoʻī: Pono ke alakaʻi e hōʻike maopopo ʻia i ka kemika terminal ma mua o ka waiho ʻana i ka inference.

Hooia: hiki iā ʻoe ke kuhikuhi i kahi laina ma ka CoA a i ʻole ka pepa kikoʻī e hōʻike ana i kēlā me kēia palena ma ka inoa.

ʻanuʻu 2: E ʻike i ke ʻano Counterion a me ka Paʻakai

Hoʻohuihui Peptide Ma ka hopena o kēia ʻanuʻu e ʻike ʻoe i ka counterion āu e lawe ai, ʻehia paha ka nui o ka vial, a ua lawa paha kēlā ʻokoʻa e neʻe ai i kāu hoʻāʻo. ʻO ka peptide counterion a me ka paʻakai ka papa kuhikuhi mua i pili ʻole i ke kaʻina a me nā mea āpau e pili ana i ka ʻano..

ʻO TFA ka counterion synthesis solid-phase paʻamau, hoʻohana ʻia ma ke ʻano he cleavage agent a me ka ion-pairing reagent, no laila hiki mai ka mea ma ke ʻano he paʻakai TFA (Erckes et al., Nā lāʻau lapaʻau 2025). Hoʻopaʻa ʻia ia e ka pairing electrostatic ikaika a ʻaʻole wehe ʻia e ka lyophilization mua. ʻAʻole mea liʻiliʻi ka nui: ma kahi 2025 ETH Zurich aʻo ma Nā lāʻau lapaʻau, Ua hōʻea ʻo TFA⁻ a hiki i 35% o ka nui o ke kaumaha ma waena o nā peptides hoʻohālike ʻehiku, kū'ē i kahi manaʻo stoichiometric e pili ana 25% (Erckes et al. 2025).

ʻAʻole hoʻololi nā counterter i ke kaʻina covalent, akā, hoʻololi lākou i ke kūpaʻa, conformation, ka pilina o ka membrane a me ka hana olaola. ʻElua mau hopena kūpono. Hoʻopau ʻo TFA i ka hoʻopaʻa ʻana i ka ion ESI-MS ma o ka hoʻohui ʻana i ka ion, a ua hoʻololi nui ka acetate iā ia i ka peptide drug synthesis, kahi i hoʻopilikia maikaʻi ʻole ai ka TFA i ke kūpaʻa a me ka hana (Nā biomolele 2025). He ʻāpana ʻokoʻa ka hoʻololi ʻana: ʻekolu pōʻai kūʻai kūʻai i hoʻemi i ke koena TFA i 0.215 ± 0.023 mg per mg peptide paʻakai mai kahi hoʻomaka 0.333 ± 0.008 mg/mg (Erckes et al. 2025). He loiloi hoʻohālikelike i ka Nūpepa o ka ʻepekema Peptide ua ʻike ʻia ua hāʻawi ʻia ka ʻāpana hoʻololi o ka HPLC a me ka resin hoʻololi ion i ka hoʻololi kokoke loa i ka lanreotide., ʻoiai ka pōʻaiapuni deprotonation/reprotonation i hoʻopau loa iā ia; ʻo ke ala maʻamau-lyophilization-me-excess-HCl e pono ai ka pH ma lalo 1 a hiki ke hoʻohaʻahaʻa i ka peptide (ʻO Roux et al., J Pept Sci 2008).

Hooia: ʻO ka palapala hōʻoia no ka hoʻopaʻa inoa ʻana i ka counterion, a me ke kūpono o kāna maʻiʻo i ana ʻia, ma mua o ka waiho ʻana iā ʻoe e infer mai ke ʻano synthesis.

ʻanuʻu 3: E hoʻololi i ka nui o ka Vial Mass i ka maʻiʻo Peptide Net

I ka pau ʻana o kēia ʻanuʻu, e ʻike ʻoe i ka nui peptide maoli i loko o ka hue ma mua o ka nui i paʻi ʻia ma ka lepili. ʻO ka ʻikepili peptide Net ka hapa o ka pauka pauka he peptide; ʻo ke koena he counterion, wai a me nā paʻakai koena. He maʻalahi ka helu helu a ʻaʻole hewa: 10 mg o ka pauda ma 70% nā hua peptide net 7 mg o ka peptide, no laila, ʻo ka nānā ʻole ʻana i ka ʻike ma ka ʻupena e hoʻomāhuahua i ka manaʻo 43%, a he a 10 i loko o ka pahu mg wale nō 6 i 8 mg o ka peptide maoli (ChemVerify, kiʻi ʻia 2026-03-20).

Hoʻopuka ʻia nā pae maʻiʻo peptide maʻamau 60 i 85% no na paakai TFA, 70 i 90% no ka acetates a me 75 i 90% no ka HCl, me ka pōkole multi-basic peptides e like me ka haʻahaʻa 50 i 60% a me nā peptides haʻahaʻa haʻahaʻa lōʻihi ma 80 i 90%. Loaʻa kēia mau helu mai kahi keʻena hoʻokolohua mea kūʻai aku, me ka nānā ʻole ʻia e nā hoa i luna, no laila e mālama iā lākou e like me nā manaʻolana ma mua o kahi kikoʻī. Pono e hoʻoholo ʻia ka ʻike o ka peptide net e ka nānā ʻana i ka waikawa amino, ka mea nitrogen a i ʻole UV, me ka ʻaoʻao like e wehewehe ana i ka nānā ʻana i ka waikawa amino e like me ke kūlana gula.

Hooia: hiki iā ʻoe ke haʻi i ka nui peptide āu i kaupaona maoli ai, a hōʻike i ka kikoʻī peptide no ka helu reproducibility i hana ai.

ʻanuʻu 4: E heluhelu i ke Kiʻi Maʻemaʻe me kona ʻano i hoʻopili ʻia

he meheu HPLC me ka piko nui, he poʻohiwi a me ʻelua piko liʻiliʻi i hōʻailona ʻia, me nā kelepona no ka ʻike ʻana i ka lōʻihi hawewe a me ka laina kumu hoʻohui

ʻO kahi ʻano hoʻomaʻemaʻe peptide ʻo ka hopena HPLC MS he ana pili pili, ʻaʻole kahi waiwai o ka mea. ʻO ka pākēneka āu e ʻike ai, ʻo ia ka ʻāpana kiʻekiʻe nui i puʻunaue ʻia e ka ʻāpana piko i hoʻohui ʻia ma lalo o hoʻokahi ala kikoʻī. E hoʻololi i ke kolamu a i ʻole ka pae paʻa a me nā hoʻonā hoʻonā. E hoʻopaʻa i ka gradient a me nā ʻano ʻano liʻiliʻi i ka piko nui a i ʻole e hoʻokaʻawale i waho. E hoʻoneʻe i ka lōʻihi nalu ʻike a me nā loli pane pili, no ka mea 214 i 220 Heluhelu ʻo nm i ka paʻa peptide ākea ʻoiai 280 ʻO ka nm ke koʻikoʻi i nā koena ʻala. ʻO ka hoʻonoho ʻana a me nā hoʻoholo hoʻokaʻawale poʻohiwi e hoʻoneʻe i ka helu mai kahi chromatogram like.

ʻO ia ke kumu e hiki ai i nā mea hoʻolako ʻelua ke hōʻike i ka maʻemaʻe like ʻole no nā mea i hana like i kāu assay.

No ke kōkua: e noi mau i ka chromatogram maka a me ke ʻano hoʻohui, ʻaʻole wale ka pākēneka.

ʻO ka mea maʻemaʻe HPLC ʻaʻole i hoʻokumu ʻia he mea nui like. ʻAʻohe ʻōlelo e pili ana i ke kaʻina, nuipa pololei, ʻano paʻakai, ʻano wai, a i ʻole e hui pū kekahi ʻano i hoʻoholo ʻole ʻia me kāu piko nui. ʻO kēlā mau āpau ka mea e hōʻoia ai i ka ʻike (ʻanuʻu 5) a me ka traceability nui (ʻanuʻu 6) pili.

ʻO ka manaʻolana hōʻoia ma hope o ka helu mai I Q2(R2) koi hōʻoia, pono 2024-06-14. Pili ke alakaʻi i nā kaʻina hana analytical hou a i ʻole i hoʻoponopono hou ʻia no ka hoʻokuʻu ʻana a me ka hoʻāʻo kūpaʻa a, ma ke kumu pilikia, i nā kaʻina hana hoʻomalu-hoʻolālā. ʻO nā kumu i kapa ʻia ʻo ia ka assay a i ʻole potency, ka maemae, haumia, a me ka ʻike, a ʻo kāna mau mea hōʻoia he pololei, pololei, kikoʻī, palena ʻike, palena quantitation, laina laina, a me ka laulā. Ke hōʻike ka mea hoʻolako i ka maʻemaʻe, ʻO ka nīnau kūpono ʻo ia ka mea o kēlā mau mea i hōʻoia ʻia ke ʻano, a kūʻē i ke ʻano kikoʻī.

Hooia: hiki iā ʻoe ke inoa i ke ʻano ma hope o ka helu, a ʻike ʻoe i nā nīnau e nīnau ai inā hiki ʻole iā ʻoe.

ʻanuʻu 5: E hōʻoia i ka ʻike a me ke ʻano, Aole Maemae wale

I ka pau ʻana o kēia ʻanuʻu, e paʻa ʻoe i ʻelua palapala ʻokoʻa no ka hailona hoʻokahi: he kaha nui e hōʻoiaʻiʻo ana i ka ʻike a me kahi chromatogram e hōʻike ana i ka maʻemaʻe. Pane lākou i nā nīnau like ʻole. Hōʻoia ka mass spectrometry i ka nuipa i manaʻo ʻia, ʻoiai ke ʻano hoʻomaʻemaʻe peptide HPLC MS hōʻike i ka nui o ka hōʻailona hoʻohui ʻia ka ʻano nui. ʻAʻole hoʻokumu kekahi i kekahi, nui loa me 98% ʻO ka maʻemaʻe ma ka wahi hiki ke lawe i ke kaʻina hewa.

No laila, ʻo ke ʻano o ka ʻike ʻana ma o ka spectrometry nuipa, maemae e HPLC, a me ka hōʻoia lua ma kahi e pono ai ka palapala noi. Hoʻokahi pilikia hoʻopilikia e paʻakikī i kēlā heluhelu. Hoʻopilikia ka Trifluoroacetate i ka ʻano physicochemical me ka circular dichroism a me FT-IR., hoʻololi i ke kaumaha nui, a ua hōʻike ʻia i ka hoʻonui a me ka pale ʻana i ka hoʻonui ʻana o nā cell, hoʻonui i ke kino a me ka ate, a hoʻonui i ka hana antibody-pane, e like me ka a 2025 Ke aʻo ʻana ʻo ETH Zurich ma Pharmaceuticals. ʻO kahi hiʻohiʻona kaʻawale o nā hopena counter-ion ma ka Nūpepa International o nā ʻepekema Molecular hōʻike e hiki ke hoʻopilikia ʻo TFA ʻaʻole wale me ka hoʻohālikelike physio-chemical akā pū kekahi me nā hoʻokolohua in vivo, kahi i hoʻoulu ai ʻo TFA i ka glioma cell growth dose-dependently a, i MOG35–55 EAE, ʻO ka hoʻomaka ʻana o ka maʻi ma kahi o ʻelima mau lā ma mua me ke ʻano TFA ma mua o ke ʻano acetate.

Hōʻike nā hōʻike i kahi hopena hōʻike i loaʻa ma ka paʻakai TFA ʻaʻole hiki ke hoʻololi ʻia me ka mea i loaʻa ma ka ʻano acetate.. Ma kahi o ka sterility a i ʻole ke kūlana endotoxin, ka USP <85> hoʻāʻo endotoxins bacteria wehewehe i ka palena e pili ana i ka monograph pākahi ma mua o ke kiʻi āpau.

ʻanuʻu 6: Hoʻopaʻa moʻolelo moʻolelo a me ka ʻimi ʻana i nā pūʻulu

ka nui o nā kaulahao traceability mai ka synthesis ma o ka hoʻokuʻu ʻana o QC, Hoʻopuka CoA, hoʻouna, loaa, hoʻoponopono hou a me ka waiho aliquot, me ka haku mooolelo

I ka pau ʻana o kēia ʻanuʻu, e loaʻa iā ʻoe kahi moʻolelo pae-nui e hoʻohuli ai i kahi hailona hou i mea hoʻololi hoʻokolohua ma mua o kahi hanana kūʻai, ʻo ia ka ʻāpana hope loa o kahi kikoʻī peptide no ka reproducibility.

Aia i ka moʻolelo ka mālama ʻana i ka moʻolelo no ka mea ua hoʻololi ia i ka mea. Kākau i lalo i ka mea hoʻoheheʻe hou a me kona māka, ka nui aliquot, ka helu ʻana i ka hau hau, a me ka mahana mālama, a laila e hoʻomau i ka hoʻonui ʻana i ka helu i ka holo ʻana o ka haʻawina. ʻO ka hue i hoʻoheheʻe ʻia i ʻeono manawa, ʻaʻole like ia me ka mea i hoʻoheheʻe ʻia i hoʻokahi manawa, ʻoiai ke kaʻina, kūʻē, a ua like ke kii maemae.

Hana like ka traceability. ʻO ka loiloi lot-to-lot he mea maʻamau, kaʻina hana mua no nā reagents koʻikoʻi koʻikoʻi: CLSI EP26 hailona-hoololi loiloi tests a candidate lot against the current lot using samples that span the measuring range and decision points, judged against predefined acceptance limits. FDA M10 requires lot-to-lot variability and comparability to be addressed when more than one kit lot is used in a single study, and the EBF recommends retaining enough old-lot material to bridge the two side by side. That retained material is what makes peptide certificate of analysis batch traceability auditable rather than nominal: me ka ole, a mid-study change has nothing to be compared against.

The EMA guideline on synthetic peptides makes the same point from the other direction. It requires dimers, trimers, oligomers, and aggregates to be identified specifically rather than grouped under a single “high molecular weight impurities” label, so a lot record that reports only a total impurity figure cannot support a comparability argument.

⚠️ ʻŌlelo Aʻo: a mid-study lot change without a predefined acceptance limit is an uncontrolled variable.

Hooia. You can trace any result back to a specific lot with a documented handling history: ka helu hailona, the CoA it was released against, the solvent and aliquot record, and the freeze-thaw count all resolve to one entry.

Nā hewa maʻamau e hōʻalo ai

The most consequential mistake is weighing the gross label mass instead of the net peptide content. A vial labeled 10 mg may contain roughly 43% less peptide than the label implies once counterion and water content are accounted for, so a concentration calculated from the label overestimates the actual molar amount by that margin. Hoʻopili ʻia kēlā hewa helu helu hoʻokahi i kēlā me kēia dilution downstream a hiki ke hana i kahi hana hana i hiki ʻole ke hana hou ʻia ma mua o ka nīnau ʻia ʻana o kekahi nīnau olaola..

Hoʻohālikelike i nā pākēneka maʻemaʻe mai nā ʻano HPLC like ʻole. Hiki i nā mea hoʻolako ʻelua ke hōʻike 95% a 98% no ke kaʻina like ʻoiai ke ana ʻana i nā mea like ʻole, no ka gradient, ʻO nā Peptides Synthetic kolamu kemika, a ʻo ka lōʻihi nalu ʻike e hoʻololi i ka mea i hopu ʻia e ka helu. E noi i ke ʻano me ke kiʻi, a mālama i nā pākēneka mai nā ʻano like ʻole me he mea like ʻole.

Ke manaʻo nei ua pau ka hoʻololi counterion. Hiki ke hoʻomau i ke koena trifluoroacetate ma hope o nā pōʻai hoʻololi he nui ma mua o ka hoʻopau ʻia, no laila ke waiho nei ka palapala hōʻike e hōʻike ana i kahi ʻano paʻakai me ka ʻole o ka ʻikepili counterion koena i wehe ʻia ka haku mele maoli.

Ka mālama ʻana i kahi ʻāpana hou e like me ka mea like. ʻAʻole hiki ke hoʻololi ʻia nā ʻāpana like ʻelua; ʻO ka hiʻohiʻona kikoʻī nui ka mea e hoʻokumu ai i ka hoʻomau no kahi haʻawina holo.

Ke ʻae ʻana i kahi lepili haumia hui. ʻO ka hōʻike ʻana i nā "mea haumia molecular kiʻekiʻe" ma ke ʻano he helu hoʻokahi e hūnā i ka ʻokoʻa ma waena o nā dimer, trimers, oligomers, a hōʻuluʻulu i manaʻo ʻia e ke alakaʻi EMA e ʻike ʻokoʻa ʻia.

Pehea ka holomua

Inā hele pololei nā mea a pau, ke paʻa nei ʻoe i kahi kikoʻī peptide no ka reproducibility hiki i kahi lab ke hana me ka ʻole e nīnau iā ʻoe i kahi nīnau hahai.. Kapa ʻia kēlā moʻolelo i ka chemistry terminal, ka counterion me kona maʻiʻo inā loaʻa, net peptide content a pehea i hoʻoholo ʻia ai, maʻemaʻe me kāna ʻano HPLC a me nā lula hoʻohui, he ʻike ʻike, a me kahi moʻolelo hoʻopaʻa ʻana a me ka moʻolelo traceability.

ʻO ka ho'āʻo hiki ke hoʻololi nui. Pono e hoʻokō ʻia nā koina ʻae ponoʻī o kāu assay i ka wā e komo ai kahi pūʻulu hou i ke aʻo ʻana, a ʻo kāu helu helu ʻana pono e kūlike me ka nui i hāʻawi ʻia. Inā holo kekahi, ʻaʻole i piha ka moʻolelo kikoʻī, ʻaʻole ka hoʻokolohua.

E like me ka pahu hopu, kūkulu i kēlā mau kahua ʻeono i loko o ka LIMS a i ʻole ELN komo no ka hoʻokolohua ponoʻī, no laila ke hele nei ka kikoʻī me ka ʻikepili ma mua o ka noho ʻana i kahi palena puke puke lab.

Nīnau pinepine

Ua lawa ke kaʻina peptide e hana hou i kahi hoʻokolohua?

ʻAʻole. ʻO ke kaula kaʻina e wehewehe i ka pilina wale nō. ʻO ke kemika terminal, ʻano hoʻohālikelike a me ka paʻakai, maʻiʻo peptide net, ʻano maʻemaʻe, ʻO ka mālama ʻana i ka mōʻaukala a me ka ʻike nui e hoʻololi i ka mea, a no laila ka hopena, oiai e waiho like ana ke kaina. ʻO kahi kikoʻī peptide no ka reproducibility ka moʻolelo piha, ʻaʻole ke kaula.

No ke aha e hāʻawi ai ka peptide like i nā helu maʻemaʻe like ʻole mai nā mea hoʻolako like ʻole?

No ka mea, ʻo ke ʻano hoʻomaʻemaʻe peptide ʻo HPLC MS hōʻike i ke ʻano pili. ʻO ka pākēneka ka ʻāpana nui-peak i hoʻohālikelike ʻia i ka ʻāpana piko i hoʻohui ʻia ma lalo o kahi ʻano kikoʻī, no laila, kolamu a me ka pae kelepona, gradient steepness, lōʻihi nalu ʻike, a me nā hoʻoholo kumu a me ka hoʻokaʻawale poʻohiwi e hoʻoneʻe i ka helu mai kahi chromatogram like. E hoʻohālikelike i nā helu maʻemaʻe wale nō ke kūlike nā ʻano hana.

ʻEhia ka hopena o ka counterion i kaʻu hopena?

ʻAʻole ia e hoʻololi i ke kaʻina covalent, akā, hoʻololi i ke kūpaʻa, conformation, ka pilina o ka membrane a me ka hana olaola. Inā he biological a i ʻole mass-spectrometric kāu assay, ʻO ka counterion kekahi hapa o ka hopena, ʻaʻole kahi kikoʻī paʻi.

He aha kaʻu e hana ai ke komo ka hailona hou i kahi haʻawina holo?

E mālama iā ia ma ke ʻano he hoʻololi hoʻokolohua. E loiloi i ka hailona o ka moho e kū'ē i ka hailona o kēia manawa me ka hoʻohana ʻana i nā laʻana e pili ana i ke ana ʻana a me nā helu hoʻoholo e pili ana i nā palena ʻae i koho mua ʻia., a mālama pono i nā mea kahiko no kahi alahaka ʻaoʻao. E kākau i ka hoʻohālikelike me nā helu hailona a me nā kahua kikoʻī i loli.

He aha inā ʻaʻole hōʻike ka CoA o kaʻu mea hoʻolako i ka ʻike peptide net?

E noi mai, a inā ʻaʻole i loaʻa, e mālama i ka nui o ka lepili ma ke ʻano he palena luna ma mua o ka nui peptide. No nā paʻakai TFA, manaʻo koʻikoʻi 80% ʻO ka maʻiʻo peptide net inā ʻaʻole i loaʻa ka waiwai he hāʻule i kākau ʻia, aka, he manao, aole he ana, a e kakau ia ma ke ano hookahi.

Ka hopena

Ke paʻa nei ʻoe i kahi kikoʻī peptide no ka reproducibility ma mua o ke kaula sequence: kemika hoʻopau, ʻano hoʻohālikelike a me ka paʻakai, maʻiʻo peptide net, he kii maemae me kona ano i hoopiliia, hōʻoia ʻike, a me ka mālama ʻana a me nā moʻolelo pūʻulu ma hope o ka mea. ʻO kēlā moʻolelo ka mea e hiki ai i kahi hoa hana ma kahi papa ʻē aʻe, a i ʻole ka pae hoʻokahi i hoʻokahi makahiki ma hope, e kauoha i kekahi mea like ma kahi o ka inoa like.

Hele ka kikoʻī me ka hoʻokolohua. E mālama iā ia me ka ʻāpana ʻano, ʻaʻole i loko o kahi waihona kūʻai, no laila hiki ke nānā ʻia ka ʻāpana aʻe i nā kahua like ma mua o ka hoʻomanaʻo. Hana ʻia ʻo Peptide

E hana hou i kāu kauoha peptide hou. E nānā i nā kahua i hōʻike maoli ʻia e kāu palapala hōʻoia o kēia manawa, a laila e hoʻohālikelike iā lākou me ke kumu kikoʻī ma mua o ka pau ʻana o ke kauoha aʻe. E ʻike i ke ʻano kikoʻī kikoʻī a nānā i nā kahua CoA e ʻike i nā mea i hoʻokomo pinepine ʻia.

Hāʻawi ʻo MOL Changes i nā peptides noiʻi-hoʻohana a kākoʻo i nā noi palapala no nā moʻolelo analytical kikoʻī.. He ʻikepili kēia ʻatikala a ʻaʻole ia he koi hoʻokō huahana; ʻO nā mea peptide i kuhikuhi ʻia ma ʻaneʻi no ka hoʻohana noiʻi, ʻaʻole no ka hoʻohana diagnostic a therapeutic paha.

Miao He

Miao He

ʻepekema noiʻi ma nā ʻōnaehana hoʻouna Kaʻike kumu: Hāʻawi peptide waha, lipid nanoparticle (LNP) hoʻopili ʻana, nā peptides komo i loko o ke kelepona (CPPs), a me nā hoʻopuka hoʻokuʻu mau.

Pilikino: ʻO nā luʻi nui i ka hoʻomohala ʻana i nā lāʻau peptide aia i loko o ko lākou mau hapalua ola pōkole a paʻakikī me ka hoʻokele waha, a ʻo Miao ʻO ia kekahi loea alakaʻi i ka hoʻoponopono ʻana i kēia mau pilikia. Loaʻa iā ia ka ʻike nui ma ke kahua o nā ʻōnaehana lawe peptide. Ke hoʻomau nei ʻo ia i ka hoʻomohala ʻana i nā mea hoʻonui permeation novel a me nā nanospheres e hoʻomaikaʻi nui i ka bioavailability o peptides..

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana